___

• REFERENCES • Abelson DC, Barton J, Mandel ID (1990). The effect of chewing sorbitol-sweetened gum on salivary flow and cemental plaque pH in subjects with low salivary flow. J Clin Dent 2: 3-5. PMid:2133392 • Andersen T, Gram-Hansen M, Pedersen M, Rassing MR (1990). Chewing gum as a drug delivery system for nystatin influence of solubilising agents upon the release of water insoluble drugs. Drug Dev Ind Pharm 16: 1985-1994. https://doi.org/10.3109/03639049009023636
• • Cherukuri SR, Pinney JM, Henningfield JE, Sasan A, Cone EJ, Shiffman S, Gitchell J, Malvestutto CD (2000). Medicated Chewing Gum Delivery System for Nicotine. US Patent No 6344222: 1-24. • Dodds MWJ, Hsieh SC, Johnson DA (1991). The effect on increased mastication by daily gum-chewing on salivary gland output and dental plaque acidogenicity. J Dent Res 70: 1474-1478. https://doi.org/10.1177/00220345910700120101 PMid:1774376 • Dong HN, Jabar F, Yilmaz C, Kai PL, DeLuca PP (2005). Chewing gum of antimicrobial decapeptide (KSL) as a sustainedcantiplaque agent. Preformulation study. J Control Release 107: 122-130. https://doi.org/10.1016/j.jconrel.2005.05.027 PMid:16009443 • Eisenstadt B, Cash AP, Bakal IA (1998). Chewing gum containing cough suppression agent. US Patent No 5,846,557. • European Pharmacopoeia, 9th edition. • Gajendran J, Kraemer J, Knudsen SR (2008). Product Performance Test for Medicated Chewing Gums.Pharmacopeial Forum 34: 15-18. • Herrera D (2005). Efficacy of a 0.15% benzydamine hydrochloride and 0.05% cetylpyridinium chloride mouth rinse on 4-day de novo plaque formation. J Clin Periodontol 32: 595-603. https://doi.org/10.1111/j.1600-051X.2005.00718.x PMid:15882217 • Kvist LC, Andersson SB, Berglund J, Wennergren B, Fors SM (2000). Equipment for drug release testing of medicated chewing gums. J Pharm Biomed Anal 22: 405-411. https://doi.org/10.1016/S0731-7085(99)00307-6
• • Liljewall LR (1992). Apparatus for mechanical processing of a sample and a member of such an apparatus.US Patent No 5,087424. • Maggi L, Segale L, Conti S, Ochoa-Machiste E, Salini A, Conte U (2005). Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device. Eur J Pharm Sci 24: 487-493. https://doi.org/10.1016/j.ejps.2005.01.010 PMid:15784338 • Mehta F, Trivedi P (2011). Formulation and texture characterization of medicated chewing gum delivery of dimenhydrinate hydrochloride. Pharm Lett 3:179-192. • Morjaria M, Irwin WJ, Barnett PX, Chan RS, Conway BR (2009). In vitro release of nicotine from chewing gum formulations. Dissolution Technol 5: 12-15. • Mostafavi SA, Varshosaz J, Arabian S (2014). Formulation development and evaluation of metformin chewing gum with bitter taste masking. Adv Biomed Res 25: 92. https://doi.org/10.4103/2277-9175.129362 PMid:24800181 PMCid:PMC4007337 • Nagaich U, Chaudhary V, Karki R, Yadav A, Sharma P (2010). Formulation of medicated chewing gum of ondansetron hydrochloride and its pharmacokinetic evaluations. Int J Pharm Sci Res 1: 32-40. • Noehr-Jensen L, Damkier P, Bidstrup TB, Pedersen RS, Nielsen F, Brosen K (2006). The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers. Eur J Clin Pharmacol 62: 437-445. https://doi.org/10.1007/s00228-006-0139-6 PMid:16770647 • Pedersen M, Rassing MR (1990). Miconazole chewing gum as a drug delivery system application of solid dispersion technique and lecithin. Drug Dev Ind Pharm 16: 2015-2030. https://doi.org/10.3109/03639049009023638 https://doi.org/10.3109/03639049009115986 https://doi.org/10.3109/03639049009023637
• • Peppas NA. (1985) Analysis of Fickian and non-fickian drug release from polymers. Pharm Acta Helv 60:110-111. PMid:4011621 • Rassing MR (1992). Chewing gum as drug delivery system. Adv Drug Deliv Rev 13: 89-121. https://doi.org/10.1016/0169-409X(94)90028-0
• • Rassing MR, Jacobsen J, Nielsen HM (2003). Chewing gum as a drug delivery system. 2th ed, Ellermann Carecom International, Denmark. • Rathbone MJ, Hadgraft J, Roberts MS (2002). Modified-release drug delivery technology. New York: Marcel Dekker: 1-8. https://doi.org/10.1201/9780203910337
• • Rowe RC (2003). By gum- a buccal delivery system. Drug Delivery Today 8: 617-618. https://doi.org/10.1016/S1359-6446(03)02728-4
• • Stojanov M, Larsen KL (2012). Cetirizine release from cyclodextrin formulated compressed chewing gum. Drug Dev Ind Pharm 38: 1061-1067. https://doi.org/10.3109/03639045.2011.638301 PMid:22185653 • Swamy NGN, Rupa V, Abbas Z, Dasankoppa FS (2010). Formulation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble mebendazole. Indian Drugs 47: 47-54. • Swamy NGN, Shilpa P, Abbas Z (2012). Formulation and characterization of medicated chewing gums of dextromethorphan hydrobromide. Indian Drugs 49: 29-35. • Testa ES (1999). Medicated chewing gum and process for preparing thereof. US Patent No 5,866,179. • Tyrpin HT, Russell MP, Witkewitz DL, Johnson SS, Ream RL, Corriveau CL (2002). Caffeine coated chewing gum product and process of making. US Patent No 6444241: 1-15. • Woodford DW, Lesko LJ (1981). Relative bioavailability of aspirin gum. J Pharm Sci 70:1341-1343. https://doi.org/10.1002/jps.2600701213 PMid:7320849 • Zyck DJ, Greenberg MJ, Barkalow DG, Marske SW, Schnell PG, Mazzone P (2003). Method of making coated chewing gum products containing various antacids. US Patent No 6645535: 1-14.